Havemann K - Search Results

1

Determining carboplatin/etoposide dosage in extensive stage small-cell lung cancer (SCLC).

Wolf M, Tessen HW, Goerg C, Achterrath W, Drings P, Havemann K. Wolf M, et al. Among authors: havemann k. Ann Oncol. 1991 May;2(5):361-4. doi: 10.1093/oxfordjournals.annonc.a057957. Ann Oncol. 1991. PMID: 1659449 Free article. Clinical Trial.

2

Alternating chemotherapy in small cell lung cancer.

Wolf M, Havemann K. Wolf M, et al. Among authors: havemann k. Onkologie. 1990 Jun;13(3):157-64. doi: 10.1159/000216751. Onkologie. 1990. PMID: 2168532 Review.

3

The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.

Wolf M, Havemann K, Holle R, Harms V, Drings P, Hans K, Dombrowski H, Victor N. Wolf M, et al. Among authors: havemann k. Eur J Cancer Clin Oncol. 1987 Aug;23(8):1197-205. doi: 10.1016/0277-5379(87)90155-6. Eur J Cancer Clin Oncol. 1987. PMID: 2443363 Clinical Trial.

4

Experience of a German multicenter study group with ifosfamide in small cell lung cancer.

Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H. Havemann K, et al. Semin Oncol. 1989 Feb;16(1 Suppl 3):9-18. Semin Oncol. 1989. PMID: 2539648 Clinical Trial.

5

Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.

Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S, et al. Wolf M, et al. Among authors: havemann k. J Clin Oncol. 1987 Dec;5(12):1880-9. doi: 10.1200/JCO.1987.5.12.1880. J Clin Oncol. 1987. PMID: 2824710 Clinical Trial.

6

[Incidence of recurrence and long-term survival in small cell bronchial carcinoma].

Wolf M, Havemann K, Holle R, Drings P, Hans K, Schroeder M. Wolf M, et al. Among authors: havemann k. Onkologie. 1987 Dec;10(6):357-66. doi: 10.1159/000216444. Onkologie. 1987. PMID: 2831490 Clinical Trial. German.

7

Paclitaxel and simultaneous radiation in the treatment of stage III A/B non-small cell lung cancer.

Havemann K, Wolf M, Goerg C, Faoro C, Pfab R, Diergarten K. Havemann K, et al. Semin Oncol. 1995 Dec;22(6 Suppl 14):19-22. Semin Oncol. 1995. PMID: 8553078 Clinical Trial.

8

Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer.

Reckzeh B, Merte H, Pflüger KH, Pfab R, Wolf M, Havemann K. Reckzeh B, et al. Among authors: havemann k. J Clin Oncol. 1996 Apr;14(4):1071-6. doi: 10.1200/JCO.1996.14.4.1071. J Clin Oncol. 1996. PMID: 8648359 Clinical Trial.

9

Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.

Wolf M, Faoro C, Goerg C, Pfab R, Havemann K, Kettner H. Wolf M, et al. Among authors: havemann k. Semin Oncol. 1996 Dec;23(6 Suppl 16):108-12. Semin Oncol. 1996. PMID: 9007135

10

Carboplatin and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer.

Wolf M, Goerg C, Goerg K, Pfab R, Achterrath W, Havemann K. Wolf M, et al. Among authors: havemann k. Oncology. 1992;49 Suppl 1:71-6; discussion 77. doi: 10.1159/000227114. Oncology. 1992. PMID: 1323815 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters